- Home
- TSHA vs AIOT Comparison
TSHA vs AIOT Comparison
Compare TSHA & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- AIOT
- Stock Information
- Founded
- TSHA 2019
- AIOT 1993
- Country
- TSHA United States
- AIOT United States
- Employees
- TSHA N/A
- AIOT N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- AIOT Telecommunications Equipment
- Sector
- TSHA Health Care
- AIOT Telecommunications
- Exchange
- TSHA Nasdaq
- AIOT Nasdaq
- Market Cap
- TSHA 728.4M
- AIOT 594.8M
- IPO Year
- TSHA 2020
- AIOT N/A
- Fundamental
- Price
- TSHA $3.02
- AIOT $5.26
- Analyst Decision
- TSHA Strong Buy
- AIOT Strong Buy
- Analyst Count
- TSHA 7
- AIOT 4
- Target Price
- TSHA $8.71
- AIOT $10.50
- AVG Volume (30 Days)
- TSHA 3.5M
- AIOT 1.6M
- Earning Date
- TSHA 11-12-2025
- AIOT 11-11-2025
- Dividend Yield
- TSHA N/A
- AIOT N/A
- EPS Growth
- TSHA N/A
- AIOT N/A
- EPS
- TSHA N/A
- AIOT N/A
- Revenue
- TSHA $8,098,000.00
- AIOT $391,206,000.00
- Revenue This Year
- TSHA N/A
- AIOT $21.83
- Revenue Next Year
- TSHA N/A
- AIOT $10.13
- P/E Ratio
- TSHA N/A
- AIOT N/A
- Revenue Growth
- TSHA N/A
- AIOT 119.82
- 52 Week Low
- TSHA $1.05
- AIOT $3.70
- 52 Week High
- TSHA $3.40
- AIOT $8.71
- Technical
- Relative Strength Index (RSI)
- TSHA 51.14
- AIOT 67.41
- Support Level
- TSHA $3.16
- AIOT $4.80
- Resistance Level
- TSHA $2.99
- AIOT $5.44
- Average True Range (ATR)
- TSHA 0.18
- AIOT 0.25
- MACD
- TSHA -0.01
- AIOT 0.06
- Stochastic Oscillator
- TSHA 38.21
- AIOT 83.02
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About AIOT PowerFleet Inc. Common Stock
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.